As a physician who has worked for more than 20 years as both a cytopathologist and an autopsy pathologist for an institution that pioneered the use of the decedent affairs office and places great value on the autopsy, 1,2 it is a pleasure to see articles that tout the value of cytodiagnosis in the autopsy suite. Andrade et al 3 provide evidenceshowing that postmortem tissue scrapings have reasonable accuracy in comparison with histology, and they suggest the use of scraping cytology as a means of performing a minimally invasive autopsy. A recent editorial supports the use of cytology in providing rapid and more comprehensive provisional reports. 4 The accuracy and utility of postmortem cytology for both neoplastic and nonneoplastic conditions are supported by 3 previously published cytology-histology/final autopsy diagnosis correlation studies that used scrapings and fine-needle aspiration (FNA), 5 touch preparations, 6 and scrapings, 7 respectively. It has also been suggested that postmortem cytology has the potential to cut autopsy costs either by providing a rapid, relatively inexpensive cytodiagnosis or by offering a screening tool with which pathologists can select cases that require histology and ancillary studies such as immunohistochemistry. 8 In addition, it has been noted that that postmortem cytologic preparations are of better quality and require less personnel time and equipment than frozen sections and that cytology precludes the potential for cryostat contamination and aerosolization of infectious agents.
7,9One of the arguments for the use of cytodiagnostic techniques in the autopsy is the potential for minimal disruption of the corpus in an era when next-of-kin full-autopsy consent has become more difficult to obtain and decedent affairs officers, trained to communicate with family members, are rare and vanishing. However, cytodiagnostic techniques also have the potential to contribute to the full autopsy, especially in an academic institution 5 where complete autopsies are needed to train house officers and for multidisciplinary conferences. I have used scrapings, FNA smears, and FNA and fluid cytocentrifuge preparations since 1991 to establish preliminary autopsy diagnoses (PADs) and direct the use of ancillary testing such as microbial cultures and special stains. We have limited the use of postmortem cytologic sampling to regions with either visible or palpable lesions, diffuse consolidations, or organs with clinical or radiologic evidence of disease; we have thus increased the likelihood that cytology will provide useful information. Gradually, postmortem cytology has been introduced into our armamentarium of postmortem diagnostic tools and has been used, albeit selectively, at our institution for many years. Whenever possible, a cytopathologist has reviewed cytologic preparations with residents or faculty on the autopsy service before the PAD is issued, and occasionally, images of interesting cytologic findings have been shown during gross organ conferences. Ideally, this should be done af...